TRUP icon

Trupanion

50.83 USD
+0.23
0.45%
At close Jun 13, 4:00 PM EDT
After hours
50.83
+0.00
0.00%
1 day
0.45%
5 days
1.66%
1 month
11.49%
3 months
51.37%
6 months
-3.60%
Year to date
5.46%
1 year
86.88%
5 years
38.92%
10 years
512.41%
 

About: Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

Employees: 1,130

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.83% more ownership

Funds ownership: 91.79% [Q4 2024] → 92.63% (+0.83%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q4 2024] → 5 (+0) [Q1 2025]

1% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 75

8% less funds holding

Funds holding: 236 [Q4 2024] → 216 (-20) [Q1 2025]

12% less call options, than puts

Call options by funds: $31.9M | Put options by funds: $36.2M

22% less capital invested

Capital invested by funds: $1.87B [Q4 2024] → $1.47B (-$406M) [Q1 2025]

39% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 44

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$60
18%
upside
Avg. target
$60
18%
upside
High target
$60
18%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Lake Street
Mark Argento
18%upside
$60
Buy
Maintained
2 May 2025

Financial journalist opinion

Based on 3 articles about TRUP published over the past 30 days

Positive
Zacks Investment Research
1 day ago
5 Accident & Health Insurance Stocks to Watch as Exposure Increases
Accident & Health Insurers AFL, UNM, TRUP, GL and AMSF are set to gain from rising underwriting exposure, despite ongoing pricing pressure.
5 Accident & Health Insurance Stocks to Watch as Exposure Increases
Positive
Zacks Investment Research
5 days ago
Trupanion (TRUP) Upgraded to Buy: What Does It Mean for the Stock?
Trupanion (TRUP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Trupanion (TRUP) Upgraded to Buy: What Does It Mean for the Stock?
Neutral
GlobeNewsWire
2 weeks ago
Trupanion to Present at the William Blair 45th Annual Growth Stock Conference
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today that Margi Tooth, Chief Executive Officer and President, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, at 3:20 p.m. CT and will participate in meetings with investors throughout the day.
Trupanion to Present at the William Blair 45th Annual Growth Stock Conference
Neutral
GlobeNewsWire
1 month ago
Top Animal Health Experts Address H5N1 Bird Flu in Trupanion Webinar
Panelists from the American Veterinary Medical Association, World Small Animal Veterinary Association One Health Committee, and others will share critical updates on H5N1 bird flu Panelists from the American Veterinary Medical Association, World Small Animal Veterinary Association One Health Committee, and others will share critical updates on H5N1 bird flu
Top Animal Health Experts Address H5N1 Bird Flu in Trupanion Webinar
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts Believe Trupanion (TRUP) Could Rally 50.25%: Here's is How to Trade
The mean of analysts' price targets for Trupanion (TRUP) points to a 50.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe Trupanion (TRUP) Could Rally 50.25%: Here's is How to Trade
Neutral
Seeking Alpha
1 month ago
Trupanion, Inc. (TRUP) Q1 2025 Earnings Call Transcript
Trupanion, Inc. (NASDAQ:TRUP ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Gil Melchior - Director of Investor Relations Margi Tooth - President & Chief Executive Officer Fawwad Qureshi - Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair Jonathan Block - Stifel John Barnidge - Piper Sandler Katie Sakys - Autonomous Research Wilma Burdis - Raymond James Josh Shanker - Bank of America Operator Good day and welcome to the Trupanion First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.
Trupanion, Inc. (TRUP) Q1 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Trupanion (TRUP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Trupanion (TRUP) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Trupanion (TRUP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Negative
Zacks Investment Research
1 month ago
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
Trupanion (TRUP) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.16 per share a year ago.
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Trupanion Reports First Quarter 2025 Results
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. “Q1 was a strong start to the year, with performance ahead of plan across key metrics,” said Margi Tooth, Chief Executive Officer and President of Trupanion.
Trupanion Reports First Quarter 2025 Results
Neutral
GlobeNewsWire
1 month ago
Trupanion Publishes 2024 Annual Letter to Shareholders
SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, has published its 2024 annual shareholder letter from CEO and President, Margi Tooth. The letter is now available on the Company's Investor Relations website here.
Trupanion Publishes 2024 Annual Letter to Shareholders
Charts implemented using Lightweight Charts™